Lv7
4396 积分 2026-05-11 加入
Repurposing alpelisib, an anti‐cancer drug, for the treatment of severe TIE2‐mutated venous malformations: Preliminary pharmacokinetics and pharmacodynamic data
11天前
已完结
Activity of a TIE2 inhibitor (rebastinib) in a patient with a life‐threatening cervicofacial venous malformation
11天前
已完结
Combination of dabrafenib plus trametinib for BRAF and MEK inhibitor pretreated patients with advanced BRAFV600-mutant melanoma: an open-label, single arm, dual-centre, phase 2 clinical trial
16天前
已完结
LTBK-01. UPDATES ON THE PHASE II AND RE-TREATMENT STUDY OF AZD6244 (SELUMETINIB) FOR CHILDREN WITH RECURRENT OR REFRACTORY PEDIATRIC LOW GRADE GLIOMA: A PEDIATRIC BRAIN TUMOR CONSORTIUM (PBTC) STUDY
18天前
已完结
Safety, pharmacokinetics, and antitumor activity of AMG 386, a selective angiopoietin inhibitor, in adult patients with advanced solid tumors
1个月前
已完结
Phase Ib Clinical and Pharmacodynamic Study of the TIE2 Kinase Inhibitor Rebastinib with Paclitaxel or Eribulin in HER2-Negative Metastatic Breast Cancer
1个月前
已完结
Identification of Somatic Genetic Variants in Superficial Vascular Malformations by Liquid Biopsy in a Cohort of 88 Patients from a French Hospital
1个月前
已完结
Cell-free DNA obtained during sclerotherapy as a method for molecular analysis of venous and lymphatic malformations
1个月前
已完结
Alpelisib for TEK ‐ and PIK3CA ‐Related Venous Malformations: A Systematic Review
1个月前
已完结
Sirolimus for Venous Malformations: A Systematic Review of Efficacy and Safety
1个月前
已完结
皖公网安备34019202002308
